Figure 1. Pharmacokinetics of aciclovir and valaciclovir. Valaciclovir (Val-ACV) is a prodrug of the antiviral compound aciclovir (ACV). Oral administration of valaciclovir yields systemic aciclovir through uptake by dipeptide transporters in the gut lumen and hydrolysis by esterases present in the gut lumen, intestinal wall and liver. >95% of administered valaciclovir is converted into aciclovir.

Figure 1. Pharmacokinetics of aciclovir and valaciclovir. Valaciclovir (Val-ACV) is a prodrug of the antiviral compound aciclovir (ACV). Oral administration of valaciclovir yields systemic aciclovir through uptake by dipeptide transporters in the gut lumen and hydrolysis by esterases present in the gut lumen, intestinal wall and liver. >95% of administered valaciclovir is converted into aciclovir.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close